Cargando…

Therapeutic Potential of PPARγ Activation in Stroke

Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptio...

Descripción completa

Detalles Bibliográficos
Autor principal: Vemuganti, Raghu
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293414/
https://www.ncbi.nlm.nih.gov/pubmed/21909480
http://dx.doi.org/10.1155/2008/461981
_version_ 1782152531857637376
author Vemuganti, Raghu
author_facet Vemuganti, Raghu
author_sort Vemuganti, Raghu
collection PubMed
description Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of genes that promote these pathophysiological mechanisms can be an effective strategy to minimize the poststroke neuronal death. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors known to be upstream to many inflammatory and antioxidant genes. The goal of this review is to discuss the therapeutic potential and putative mechanisms of neuroprotection following PPAR activation after stroke.
format Text
id pubmed-2293414
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-22934142008-04-22 Therapeutic Potential of PPARγ Activation in Stroke Vemuganti, Raghu PPAR Res Review Article Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of genes that promote these pathophysiological mechanisms can be an effective strategy to minimize the poststroke neuronal death. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors known to be upstream to many inflammatory and antioxidant genes. The goal of this review is to discuss the therapeutic potential and putative mechanisms of neuroprotection following PPAR activation after stroke. Hindawi Publishing Corporation 2008 2008-04-13 /pmc/articles/PMC2293414/ /pubmed/21909480 http://dx.doi.org/10.1155/2008/461981 Text en Copyright © 2008 Raghu Vemuganti. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Vemuganti, Raghu
Therapeutic Potential of PPARγ Activation in Stroke
title Therapeutic Potential of PPARγ Activation in Stroke
title_full Therapeutic Potential of PPARγ Activation in Stroke
title_fullStr Therapeutic Potential of PPARγ Activation in Stroke
title_full_unstemmed Therapeutic Potential of PPARγ Activation in Stroke
title_short Therapeutic Potential of PPARγ Activation in Stroke
title_sort therapeutic potential of pparγ activation in stroke
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293414/
https://www.ncbi.nlm.nih.gov/pubmed/21909480
http://dx.doi.org/10.1155/2008/461981
work_keys_str_mv AT vemugantiraghu therapeuticpotentialofppargactivationinstroke